BIOMUTANT
Short description
BIOMUTANT is an open-world, post-apocalyptic Kung-Fu fable RPG, with a unique martial arts styled combat system allowing you to mix melee, shooting and mutant ability action.
- Developer
- Experiment 101
- Publisher
- THQ Nordic
- Release
- Tue, May 25, 2021
- Price
- $39.99
- Reviews
- 13,187
- Positive
- 67%
- Followers
- 187,775
- Owners (estimated)
- 1M – 2M
- Concurrent players
- 37
- Genres
- Action, RPG
- Features
- Full controller support, Steam Trading Cards, Remote Play on Tablet
- Tags
Review count and SteamSpy's owner range agree well enough to narrow the estimate down to this band. Multiplied by $38.45, the average price these copies actually sold for — weighted from the price history rather than taken from the $39.99 launch price. That is 4% below list price on average. Before Steam's cut, VAT and refunds. How these numbers are calculated.
Waiting for BIOMUTANT to get cheaper? Name your price and we will email you when it gets there.
History
85 data points since Aug 1, 2026. Gaps mean nothing changed — the value carries forward.
The revenue curve is an estimate, not a measurement. It is the only calculated series here: each interval takes the review growth of that period, multiplies it by the sales-per-review factor and by the price actually charged at the time, and adds the result to the running total. That is why it climbs more slowly through discount periods than the review curve next to it. The last point is the same figure quoted above — gross, before Steam's cut, VAT and refunds. How these numbers are calculated.
The blurred area is the rest of the history. 141 further data points reach back to Jan 1, 2018 — your plan shows the last 90 days of it. How far each series in particular reaches is written on its own chart; not every one of them goes back that far. The shape in the blurred area is decoration, not data: the figures are not in this page at all. Plus unlocks the complete series.
Lowest recorded price: $9.99 on Aug 1, 2024.
Similar games that found an audience
Games sharing at least 3 of this title's leading tags, with enough reviews to have gone somewhere. Ranked by how much they overlap, not by how big they are. − missing and + extra mark the tags each one does not share with BIOMUTANT. Studio counts the titles that developer has released — the closest thing to production scale that public data allows. It is not a budget, and nobody publishes those.
| Image | Name | Studio | Shared | Tag difference | Price | Reviews | Positive | Released | Revenue (estimated) |
|---|---|---|---|---|---|---|---|---|---|
|
The Elder Scrolls V: Skyrim Special Edition | Bethesda Game Studios 13 titles | 5 | − Action + Fantasy | $39.99 | 222,285 | 94% | Fri, Oct 28, 2016 | $346m $173m – $346m |
|
Middle-earth: Shadow of War | Monolith Productions 8 titles | 5 | − Character Customization + Fantasy | $49.99 | 88,199 | 89% | Mon, Oct 09, 2017 | $172m $86.5m – $216m |
|
Assassin's Creed Valhalla | Ubisoft Montreal 31 titles | 5 | − Character Customization + Vikings | $59.99 | 41,728 | 70% | Tue, Dec 06, 2022 | $48.5m $40.4m – $48.5m |
|
Dragon's Dogma: Dark Arisen | Capcom 25 titles | 5 | − Singleplayer + Fantasy | $4.79 84% best price ever |
37,606 | 88% | Fri, Jan 15, 2016 | $49.4m $49.4m – $74.4m |
|
FINAL FANTASY VII REBIRTH | Square Enix 144 titles | 5 | − Character Customization + JRPG | $49.99 | 26,477 | 75% | Thu, Jan 23, 2025 | $45.6m $24.1m – $45.6m |
There are more like this. Your plan shows the 5 closest neighbours; Plus and Pro show up to 100 — enough to see the shape of a niche instead of a sample of it.